After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Lal Karsanbhai; President, Chief Executive Officer, Director; Emerson Electric Co Michael Baughman; Chief Financial Officer, Executive Vice President, Chief Accounting Officer; Emerson Electric Co Ram ...

Good day and welcome to the Emerson First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an ...

Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter ...

Pretty early in our work, Steve Ballmer and I said, God, I wish we had guys like Mike Maples here.” Goldman Sachs analyst ...

Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 ...